New Oracle Health Sciences InForm and Oracle Argus Safety Integration Accelerates Safety Reporting, Reduces Costs
Out-of-the-Box Integration Automates Adverse Event Data Transfer Using E2B Standards to Increase Efficiency and Improve Safety Data Quality
To help clinical trial sponsors and contract research organizations (CROs) more cost-effectively and efficiently capture and manage information on adverse events, Oracle has integrated Oracle Health SciencesInForm and Oracle Argus Safety. By automating the transfer of serious adverse event (SAE) and related information from the Oracle Health Sciences InForm clinical data management system to the Oracle Argus Safety system, the integration can virtually eliminate the time, and significantly reduce the costs and potential for error associated with reformatting and rekeying data. The out-of-the-box integration, which supports both drug and medical device trials, provides a proven, robust, and configurable integration between Oracle Health Sciences InForm and Oracle Argus Safety that speeds time to deployment, virtually eliminates custom development costs, and allows managers to select how often SAE information and updates are delivered to the safety system, as well as whether the information is transmitted automatically or based on user action.
Adverse event information from Oracle Health Sciences InForm is now available to safety teams within minutes as opposed to hours or days, allowing sponsors and CROs to assess potential SAEs faster and facilitate compliance with regulatory reporting requirements. Organizations can also save valuable time at the end of an electronic data capture (EDC) trial by avoiding time-consuming reconciliations between data across the clinical data management and safety systems. This closed-loop solution is designed to improve cross-organizational communication and provides up-to-date information by returning Oracle Argus Safety case numbers and status notifications back to Oracle Health Sciences InForm.
“Out-of-the-box integration between Oracle Health Sciences InForm and Oracle Argus Safety helps trial sponsors and CROs to respond faster to potential SAEs while reducing the costs and potential for error involved in rekeying information. It also ensures consistent information between the clinical data management and safety systems, which expedites data validation at the end of a trial, ultimately accelerating time to regulatory submission,” said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
